Valion Bio, Inc. VBIO
0.54 USD +0.01 (+1.71%)
Nov 3, 2026, 2:59 PM EST
0.505 Day range 0.5627
0.505 52-week range 67.50
- YTD
- -98.51%
- 1 year
- -99.09%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -7.90M | -4.48M | -8.24M | -10.10M | -5.63M | |
| -8.88M | -5.66M | -8.24M | -10.10M | -8.49M | |
| -196.00 | -492.00 | -4,420.00 | -44,336.00 | -103,275.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 12.64M | 2.00M | 3.40M | 3.52M | 12.97M | |
| 31.61M | 2.81M | 5.16M | 5.88M | 15.04M | |
| 7.44M | 272.00K | 1.58M | 2.25M | 1.76M | |
| 6.45M | 0 | 369.00K | 530.00K | 708.00K | |
| 16.80M | 2.54M | 3.58M | 3.63M | 13.27M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -7.00M | -5.72M | -8.51M | -8.92M | -5.61M | |
| -705.00K | 0 | -118.00K | -11.00K | 0 | |
| 18.35M | 4.33M | 8.51M | -528.00K | 17.54M | |
| -38.00K | 0 | -118.00K | -11.00K | 0 | |
| 10.64M | -1.39M | -122.00K | -9.46M | 11.93M |